STABILITY OF CISPLATIN, IPROPLATIN, CARBOPLATIN, AND TETRAPLATIN IN COMMONLY USED INTRAVENOUS SOLUTIONS

被引：59

作者：

CHEUNG, YW

CRADOCK, JC

VISHNUVAJJALA, BR

FLORA, KP

机构：

[1] NCI,DIV CANC TREATMENT,DEV THERAPEUT PROGRAM,PHARMACEUT RES BRANCH,BLDG 37,ROOM 6D12,BETHESDA,MD 20892

[2] NCI,ANALYT & PROD DEV SECT,BETHESDA,MD 20892

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1987年 / 44卷 / 01期

关键词：

D O I：

10.1093/ajhp/44.1.124

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：124 / 130

页数：7

共 24 条

[1] BOVEN E, 1985, CANCER RES, V45, P86
[2] EINHORN L H, 1977, Journal of Clinical Hematology and Oncology, V7, P662
[3] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER
EINHORN, LH
DONOHUE, J
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) : 293 - 298
[4] CURRENT CONCEPTS IN CANCER - ROLE OF CIS-PLATINUM IN SOLID-TUMOR THERAPY
EINHORN, LH
WILLIAMS, SD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) : 289 - 291
[5] STABILITY OF CISPLATIN IN AQUEOUS-SOLUTION
GREENE, RF
CHATTERJI, DC
HIRANAKA, PK
GALLELLI, JF
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (01): : 38 - 43
[6] GUTHRIE TH, 1985, CANCER, V55, P1629, DOI 10.1002/1097-0142(19850415)55:8<1629::AID-CNCR2820550802>3.0.CO
[7] 2-I
[8] HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO
[9] 2-J
[10] Hincal A A, 1979, J Parenter Drug Assoc, V33, P107